Treatment of 48 cases of menopause syndrome by moving cupping therapy along the meridians

2004 ◽  
Vol 2 (4) ◽  
pp. 37-38
Author(s):  
Jiang Zhen-ya ◽  
He Ling-na ◽  
Li Chang-du
2019 ◽  
Author(s):  
Meng Xing ◽  
Xiaoning Yan ◽  
Suqing Yang ◽  
Linge Li ◽  
Liping Gong ◽  
...  

Abstract ABSTRACT Background: The clinical treatment of plaque psoriasis is based on comprehensive therapy, which is expensive and unsatisfactory, and some of the drugs currently used have serious side effects. Moving cupping therapy has been used clinically for thousands of years in China and has the advantage of being inexpensive and easy to perform. It is now widely used in public hospitals in China for the treatment of psoriasis. However, at present, a comprehensive evaluation of the current clinical evidence regarding its use is lacking. This study aims to evaluate the efficacy and safety of moving cupping in the treatment of plaque psoriasis. Methods and analysis: A multicentre, two-arm parallel group, single-blind randomised controlled trial will be conducted in six academic and non-academic hospitals in China. A total of 110 adult patients (aged 18-65 years) who meet the inclusion criteria are now being recruited. Participants will receive (1) basic treatment combined with moving cupping therapy or (2) basic treatment combined with moving cupping placebo. The treatment cycle will be 4 weeks, and the treatment efficacy will be assessed weekly using the Psoriasis Area and Severity Index during the treatment period and the follow-up visits at weeks 6 and 8. The body surface area, physician's global assessment, Dermatology Life Quality Index, patient-reported quality of life, visual analogy scale, traditional Chinese medication syndrome scoring scale, combined medication, and adverse events will also be recorded and compared to the baseline values. Discussion: The results of this trial may help make better decisions in the treatment of plaque psoriasis. If the results are considered to be favorable, this ancient Chinese medicine therapy may be worthier of promotion because of its convenience and cheap advantages to benefit patients. Trial registration: This study has been registered at ClinicalTrials.gov under the identifier number NCT03952676. Registered on 15 May 2019.


Trials ◽  
2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Meng Xing ◽  
Xiaoning Yan ◽  
Suqing Yang ◽  
Linge Li ◽  
Liping Gong ◽  
...  

Medicine ◽  
2020 ◽  
Vol 99 (41) ◽  
pp. e22539
Author(s):  
Meng Xing ◽  
Xiaojie Ding ◽  
Jinjing Zhang ◽  
Le Kuai ◽  
Yi Ru ◽  
...  

2020 ◽  
Author(s):  
Meng Xing ◽  
Xiaoning Yan ◽  
Suqing Yang ◽  
Linge Li ◽  
Liping Gong ◽  
...  

Abstract Background: The clinical treatment of plaque psoriasis is based on comprehensive therapy, which is expensive and unsatisfactory, and some of the drugs currently used have serious side effects. Moving cupping therapy has been used clinically for thousands of years in China and has the advantage of being inexpensive and easy to perform. It is now widely used in public hospitals in China for the treatment of psoriasis. However, at present, a comprehensive evaluation of the current clinical evidence regarding its use is lacking. This study aims to evaluate the efficacy and safety of moving cupping in the treatment of plaque psoriasis. Methods and analysis: A multicentre, two-arm parallel group, single-blind randomised controlled trial will be conducted in six academic and non-academic hospitals in China. A total of 110 adult patients (aged 18-65 years) who meet the inclusion criteria are now being recruited. Participants will receive (1) basic treatment combined with moving cupping therapy or (2) basic treatment combined with moving cupping placebo. The treatment cycle will be 4 weeks, and the treatment efficacy will be assessed weekly using the Psoriasis Area and Severity Index during the treatment period and the follow-up visits at weeks 6 and 8. The body surface area, physician's global assessment, Dermatology Life Quality Index, patient-reported quality of life, visual analogy scale, traditional Chinese medication syndrome scoring scale, combined medication, and adverse events will also be recorded and compared to the baseline values. Discussion: The results of this trial may help make better decisions in the treatment of plaque psoriasis. If the results are considered to be favorable, this ancient Chinese medicine therapy may be worthier of promotion because of its convenience and cheap advantages to benefit patients. Trial registration: This study has been registered at ClinicalTrials.gov under the identifier number NCT03952676. Registered on 15 May 2019.


2020 ◽  
Author(s):  
Meng Xing ◽  
Xiaoning Yan ◽  
Suqing Yang ◽  
Linge Li ◽  
Liping Gong ◽  
...  

Abstract Background: The clinical treatment of plaque psoriasis is based on comprehensive therapy, which is expensive and unsatisfactory, and some of the drugs currently used have serious side effects. Moving cupping therapy has been used clinically for thousands of years in China and has the advantage of being inexpensive and easy to perform. It is now widely used in public hospitals in China for the treatment of psoriasis. However, at present, a comprehensive evaluation of the current clinical evidence regarding its use is lacking. This study aims to evaluate the efficacy and safety of moving cupping in the treatment of plaque psoriasis. Methods and analysis: A multicentre, two-arm parallel group, single-blind randomised controlled trial will be conducted in six academic and non-academic hospitals in China. A total of 110 adult patients (aged 18-65 years) who meet the inclusion criteria are now being recruited. Participants will receive (1) basic treatment combined with moving cupping therapy or (2) basic treatment combined with moving cupping placebo. The treatment cycle will be 4 weeks, and the treatment efficacy will be assessed weekly using the Psoriasis Area and Severity Index during the treatment period and the follow-up visits at weeks 6 and 8. The body surface area, physician's global assessment, Dermatology Life Quality Index, patient-reported quality of life, visual analogy scale, traditional Chinese medication syndrome scoring scale, combined medication, and adverse events will also be recorded and compared to the baseline values. Discussion: The results of this trial may help make better decisions in the treatment of plaque psoriasis. If the results are considered to be favorable, this ancient Chinese medicine therapy may be worthier of promotion because of its convenience and cheap advantages to benefit patients. Trial registration: This study has been registered at ClinicalTrials.gov under the identifier number NCT03952676. Registered on 15 May 2019.


2018 ◽  
Vol 86 (March) ◽  
pp. 63-67
Author(s):  
SAMAR K. AL-NOUMANY, M.Sc. AZZA A. ABD EL-HADY, Ph.D. ◽  
BASANT H. EL-REFAY, Ph.D. MOHSEN M. HELMY, M.D.

Author(s):  
Xiangfeng He ◽  
Xueyan Zhang ◽  
Fuyuan Liao ◽  
Li He ◽  
Xin Xu ◽  
...  

BACKGROUND: Various cupping sizes of cupping therapy have been used in managing musculoskeletal conditions; however, the effect of cupping sizes on skin blood flow (SBF) responses is largely unknown. OBJECTIVE: The objective of this study was to compare the effect of three cupping sizes of cupping therapy on SBF responses. METHODS: Laser Doppler flowmetry (LDF) was used to measure SBF on the triceps in 12 healthy participants in this repeated measures study. Three cup sizes (35, 40 and 45 mm in diameter) were blinded to the participants and were tested at -300 mmHg for 5 minutes. Reactive hyperemic response to cupping therapy was expressed as a ratio of baseline SBF. RESULTS: All three sizes of cupping cups resulted in a significant increase in peak SBF (p< 0.001). Peak SBF of the 45 mm cup (9.41 ± 1.32 times) was significantly higher than the 35 mm cup (5.62 ± 1.42 times, p< 0.05). Total SBF of the 45 mm cup ((24.33 ± 8.72) × 103 times) was significantly higher than the 35 mm cup ((8.05 ± 1.63) × 103 times, p< 0.05). Recovery time of the 45 mm cup (287.46 ± 39.54 seconds) was significantly longer than the 35 mm cup (180.12 ± 1.42 seconds, p< 0.05). CONCLUSIONS: Our results show that all three cup sizes can significantly increase SBF. The 45 mm cup is more effective in increasing SBF compared to the 35 mm cup.


Sign in / Sign up

Export Citation Format

Share Document